Guardant Health vs Veracyte: revenue, profit, margins and growth compared
Guardant Health brought in $982M of revenue in fiscal 2025, Veracyte $517.1M in fiscal 2025. Revenue changed by +32.9% at Guardant Health and +16.0% at Veracyte on the year before, so Guardant Health grew faster. Guardant Health kept -42.4% of its revenue as net profit, Veracyte 12.8%. Free cash flow was -$233.1M at Guardant Health and $126.6M at Veracyte.
Fiscal years as each company reports them; the two may end in different months.
Questions about Guardant Health and Veracyte
Which is bigger by revenue, Guardant Health or Veracyte?
Guardant Health is bigger by revenue: $982M in fiscal 2025, against $517.1M for Veracyte in fiscal 2025.
Which keeps more of its revenue as profit, Guardant Health or Veracyte?
Guardant Health had a net margin of -42.4% in fiscal 2025; Veracyte had 12.8% in fiscal 2025.
Which grew revenue faster, Guardant Health or Veracyte?
In their latest fiscal years revenue changed by +32.9% at Guardant Health and +16.0% at Veracyte.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.